Anti-ERCC8 antibody [EPR9237] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal ERCC8 antibody. Carrier free. Suitable for IP, WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
CKN1, CSA, ERCC8, DNA excision repair protein ERCC-8, Cockayne syndrome WD repeat protein CSA
- IP
Lab
Immunoprecipitation - Anti-ERCC8 antibody [EPR9237] - BSA and Azide free (AB240096)
This data was developed using ab137033, the same antibody clone in a different buffer formulation.
Purified ab137033 at 1/80 dilution (2μg) immunoprecipitating ERCC8 in HeLa whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab137033 + HeLa whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab137033 in HeLa whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/5000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 44 kDa
All lanes:
Immunoprecipitation - Anti-ERCC8 antibody [EPR9237] (<a href='/en-us/products/primary-antibodies/ercc8-antibody-epr9237-ab137033'>ab137033</a>)
Predicted band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-ERCC8 antibody [EPR9237] - BSA and Azide free (AB240096)
This data was developed using ab137033, the same antibody clone in a different buffer formulation.
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : ERCC8 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Molt-4 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab137033 observed at 44 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab137033 was shown to recognize ERCC8 when ERCC8 knockout samples were used, along with additional cross-reactive bands. Wild-type and ERCC8 knockout samples were subjected to SDS-PAGE. ab137033 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively, and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-ERCC8 antibody [EPR9237] (<a href='/en-us/products/primary-antibodies/ercc8-antibody-epr9237-ab137033'>ab137033</a>)
Predicted band size: 44 kDa
false
- WB
Unknown
Western blot - Anti-ERCC8 antibody [EPR9237] - BSA and Azide free (AB240096)
This data was developed using ab137033, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-ERCC8 antibody [EPR9237] (<a href='/en-us/products/primary-antibodies/ercc8-antibody-epr9237-ab137033'>ab137033</a>) at 1/1000 dilution
Lane 1:
MOLT-4 (Human lymphoblastic leukemia T lymphoblast) whole cell lysate at 15 µg
Lane 2:
293T (Human embryonic kidney epithelial cell) whole cell lysate at 15 µg
Lane 3:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/5000 dilution
Predicted band size: 44 kDa
false
Related conjugates and formulations (1)
-
Anti-ERCC8 antibody [EPR9237]
Reactivity data
Product details
ab240096 is the carrier-free version of ab137033.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ERCC8 forms a part of the CSA complex which includes other proteins involved in the TC-NER pathway. The CSA complex targets the repair machinery to the site of transcription-blocking lesions. Identifying these lesions is critical to resuming normal transcription processes. The CSA protein therefore actively contributes to maintaining genomic stability by facilitating the correction of transcription-coupled DNA damage.
Pathways
ERCC8 participates directly in the nucleotide excision repair (NER) pathway specifically in its transcription-coupled repair subprocess. This pathway is integral to correcting helix-distorting DNA lesions that impede transcription. ERCC8 interacts closely with the Cockayne syndrome B (CSB) protein and RNA polymerase II during the repair process. This collaboration is important in modulating the restart of transcription post-repair.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Nature cell biology 26:770-783 PubMed38600236
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 46: PubMed34528699
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com